Comparison of the efficacy and tolerability profile of liraglutide, a once-daily human GLP-1 analog, in patients with type 2 diabetes ≥65 and <65 years of age: a pooled analysis from phase III studies (Q45160147)
Jump to navigation
Jump to search
scientific article published on 4 November 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of the efficacy and tolerability profile of liraglutide, a once-daily human GLP-1 analog, in patients with type 2 diabetes ≥65 and <65 years of age: a pooled analysis from phase III studies |
scientific article published on 4 November 2011 |
Statements
1 reference
Comparison of the efficacy and tolerability profile of liraglutide, a once-daily human GLP-1 analog, in patients with type 2 diabetes ≥65 and <65 years of age: a pooled analysis from phase III studies (English)
1 reference
Bruce W Bode
1 reference
Jason Brett
1 reference
Ali Falahati
1 reference
Richard E Pratley
1 reference
4 November 2011
1 reference
1 reference
9
1 reference
6
1 reference
423-433
1 reference
Identifiers
1 reference
1 reference